Cargando…

Progression of Antiviral Agents Targeting Viral Polymerases

Viral DNA and RNA polymerases are two kinds of very important enzymes that synthesize the genetic materials of the virus itself, and they have become extremely favorable targets for the development of antiviral drugs because of their relatively conserved characteristics. There are many similarities...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Siqi, Wang, Huizhen, Wang, Zhengtao, Wang, Qingzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654062/ https://www.ncbi.nlm.nih.gov/pubmed/36364196 http://dx.doi.org/10.3390/molecules27217370

Ejemplares similares

Progress on COVID-19 Chemotherapeutics Discovery and Novel Technology
por: Zhou, Yalan, et al.
Publicado: (2022)

Antiviral Agents and Viral Diseases of Man
por: Baltimore, Robert S.
Publicado: (1990)

Targeting the Viral Polymerase of Diarrhea-Causing Viruses as a Strategy to Develop a Single Broad-Spectrum Antiviral Therapy
por: Bassetto, Marcella, et al.
Publicado: (2019)

A Potent, Broad-Spectrum Antiviral Agent that Targets Viral Membranes
por: Wojcechowskyj, Jason A., et al.
Publicado: (2010)

Viral targeting of TFIIB impairs de novo polymerase II recruitment and affects antiviral immunity
por: Haas, Darya A., et al.
Publicado: (2018)

A state-of-the-art review on fucoidan as an antiviral agent to combat viral infections
por: Pradhan, Biswajita, et al.
Publicado: (2022)

Emerging paradigms of viral diseases and paramount role of natural resources as antiviral agents
por: Sagaya Jansi, R., et al.
Publicado: (2021)

Plant-Derived Antimicrobial Peptides as Potential Antiviral Agents in Systemic Viral Infections
por: Mammari, Nour, et al.
Publicado: (2021)

The Antiviral Activities of Poly-ADP-Ribose Polymerases
por: Malgras, Mathilde, et al.
Publicado: (2021)

Viral polymerase binding and broad-spectrum antiviral activity of molnupiravir against human seasonal coronaviruses
por: Wang, Yining, et al.
Publicado: (2021)

Exploring new antiviral targets for influenza and COVID-19: Mapping promising hot spots in viral RNA polymerases
por: Figueiredo-Nunes, Inês, et al.
Publicado: (2023)

The Signaling Pathways, and Therapeutic Targets of Antiviral Agents: Focusing on the Antiviral Approaches and Clinical Perspectives of Anthocyanins in the Management of Viral Diseases
por: Mohammadi Pour, Pardis, et al.
Publicado: (2019)

Identification of novel targets and pathways to distinguish suicide dependent or independent on depression diagnosis
por: Peng, Siqi, et al.
Publicado: (2023)

A Novel Approach of Antiviral Drugs Targeting Viral Genomes
por: Hoang, Phuong Thi, et al.
Publicado: (2022)

Targeting viral entry as a strategy for broad-spectrum antivirals
por: Mazzon, Michela, et al.
Publicado: (2019)

SUMOylation in Viral Replication and Antiviral Defense
por: Fan, Yao, et al.
Publicado: (2022)

Curcumin as an Antiviral Agent
por: Jennings, Morgan R., et al.
Publicado: (2020)

Ribonucleases as antiviral agents
por: Ilinskaya, O. N., et al.
Publicado: (2014)

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
por: Agostini, Maria L., et al.
Publicado: (2018)

Targeting Viral Methyltransferases: An Approach to Antiviral Treatment for ssRNA Viruses
por: Ramdhan, Peter, et al.
Publicado: (2022)

Viral Ancestors of Antiviral Systems
por: Villarreal, Luis P.
Publicado: (2011)

Novel Antiviral Agents for Respiratory Viral Infection in Immunocompromised Adults
por: Hawkinson, Dana, et al.
Publicado: (2013)

Protein arginine methylation in viral infection and antiviral immunity
por: Zheng, Kai, et al.
Publicado: (2023)

STAT3 roles in viral infection: antiviral or proviral?
por: Chang, Zhangmei, et al.
Publicado: (2018)

Seven classes of antiviral agents
por: Ianevski, Aleksandr, et al.
Publicado: (2022)

Identification of niclosamide as a novel antiviral agent against porcine epidemic diarrhea virus infection by targeting viral internalization
por: Wang, Yue, et al.
Publicado: (2023)

Antiviral Agents as Therapeutic Strategies Against Cytomegalovirus Infections
por: Chen, Shiu-Jau, et al.
Publicado: (2019)

Adenine: an important drug scaffold for the design of antiviral agents
por: Wang, Changyuan, et al.
Publicado: (2015)

The Progression of N6-methyladenosine Study and Its Role in Neuropsychiatric Disorders
por: Lei, Chunguang, et al.
Publicado: (2022)

A new antiviral scaffold for human norovirus identified with computer-aided approaches on the viral polymerase
por: Giancotti, Gilda, et al.
Publicado: (2019)

Viral polymerases
por: Menéndez-Arias, Luis, et al.
Publicado: (2017)

SARS-CoV-2 RNA polymerase as target for antiviral therapy
por: Buonaguro, Luigi, et al.
Publicado: (2020)

The Interplay of Viral and Host Factors in Chikungunya Virus Infection: Targets for Antiviral Strategies
por: Wong, Kai Zhi, et al.
Publicado: (2018)

Potential of the Other Genetic Information Coded by the Viral RNA Genomes as Antiviral Target
por: Berzal-Herranz, Alfredo, et al.
Publicado: (2019)

G-Quadruplexes in the Viral Genome: Unlocking Targets for Therapeutic Interventions and Antiviral Strategies
por: Pathak, Rajiv
Publicado: (2023)

Antiviral agents for the treatment of COVID-19: Progress and challenges
por: Singh, Manmeet, et al.
Publicado: (2022)

Viral and cellular RNA helicases as antiviral targets
por: Kwong, Ann D., et al.
Publicado: (2005)

Visualizing the Nucleotide Addition Cycle of Viral RNA-Dependent RNA Polymerase
por: Wu, Jiqin, et al.
Publicado: (2018)

Autophagy, antiviral immunity, and viral countermeasures
por: Shoji-Kawata, Sanae, et al.
Publicado: (2009)

Viral recognition and the antiviral interferon response
por: Dalskov, Louise, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9ofvus0r20q2j30mde498bj6ts